Krsnaa Diagnostics Limited (KRSNAA) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.051x

Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has a cash flow conversion efficiency ratio of 0.051x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs389.28 Million ≈ $4.21 Million USD) by net assets (Rs7.60 Billion ≈ $82.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Krsnaa Diagnostics Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Krsnaa Diagnostics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read KRSNAA total debt and obligations for a breakdown of total debt and financial obligations.

Krsnaa Diagnostics Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Krsnaa Diagnostics Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Medallion Financial Corp
NASDAQ:MFIN
0.132x
Kginicis Co.Ltd
KQ:035600
0.020x
Amcil Ltd
AU:AMH
0.012x
CSG Holding Co Ltd
SHE:200012
0.023x
Inesa Intelligent Tech Inc B
SHG:900901
-0.009x
Huxen Corp
TW:2433
0.060x
Replimune Group Inc
NASDAQ:REPL
-0.313x
Future Park Leasehold Property Fund
BK:FUTUREPF
0.037x

Annual Cash Flow Conversion Efficiency for Krsnaa Diagnostics Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Krsnaa Diagnostics Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Krsnaa Diagnostics Limited market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs8.83 Billion
≈ $95.47 Million
Rs873.27 Million
≈ $9.44 Million
0.099x +229.06%
2024-03-31 Rs8.10 Billion
≈ $87.58 Million
Rs243.45 Million
≈ $2.63 Million
0.030x -70.89%
2023-03-31 Rs7.39 Billion
≈ $79.89 Million
Rs763.01 Million
≈ $8.25 Million
0.103x -46.22%
2022-03-31 Rs6.69 Billion
≈ $72.32 Million
Rs1.28 Billion
≈ $13.89 Million
0.192x -56.58%
2021-03-31 Rs2.32 Billion
≈ $25.08 Million
Rs1.03 Billion
≈ $11.09 Million
0.442x +330.44%
2020-03-31 Rs-1.97 Billion
≈ $-21.30 Million
Rs378.09 Million
≈ $4.09 Million
-0.192x +72.02%
2019-03-31 Rs-849.21 Million
≈ $-9.18 Million
Rs582.66 Million
≈ $6.30 Million
-0.686x +52.08%
2018-03-31 Rs-228.96 Million
≈ $-2.48 Million
Rs327.85 Million
≈ $3.55 Million
-1.432x -274.29%
2017-03-31 Rs757.06 Million
≈ $8.19 Million
Rs621.99 Million
≈ $6.73 Million
0.822x --

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research
Market Cap
$206.54 Million
Rs19.10 Billion INR
Market Cap Rank
#16412 Global
#832 in India
Share Price
Rs588.75
Change (1 day)
+1.34%
52-Week Range
Rs520.30 - Rs867.05
All Time High
Rs1020.15
About

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more